NEUROLOGICAL AND PSYCHIATRIC SIDE-EFFECTS OF L-DOPA

被引:12
作者
BARBEAU, A [1 ]
机构
[1] CLIN RES INST MONTREAL, DEPT NEUROBIOL, MONTREAL H2W 1R7, QUEBEC, CANADA
来源
PHARMACOLOGY & THERAPEUTICS PART C-CLINICAL PHARMACOLOGY AND THERAPEUTICS | 1976年 / 1卷 / 3-4期
关键词
D O I
10.1016/S0362-5486(76)80032-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:475 / 494
页数:20
相关论文
共 66 条
[1]   BEHAVIOURAL AND BIOCHEMICAL EFFECTS OF L-DOPA AFTER INHIBITION OF DOPAMINE-BETA-HYDROXYLASE IN RESERPINE PRETREATED RATS [J].
AHLENIUS, S ;
ENGEL, J .
NAUNYN-SCHMIEDEBERGS ARCHIV FUR PHARMAKOLOGIE, 1971, 270 (04) :349-&
[2]   EVIDENCE FOR DOPAMINE RECEPTOR STIMULATION BY APOMORPHINE [J].
ANDEN, NE ;
RUBENSON, A ;
FUXE, K ;
HOKFELT, T .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1967, 19 (09) :627-&
[3]   EFFECTS OF CHLORPROMAZINE, HALOPERIDOL AND RESERPINE ON THE LEVELS OF PHENOLIC ACIDS IN RABBIT CORPUS STRIATUM [J].
ANDEN, NE ;
ROOS, BE ;
WERDINIUS, B .
LIFE SCIENCES, 1964, 3 (02) :149-158
[4]   DEMONSTRATION AND MAPPING OUT OF NIGRO-NEOSTRIATAL DOPAMINE NEURONS [J].
ANDEN, NE ;
CARLSSON, A ;
DAHLSTROM, A ;
FUXE, K ;
HILLARP, NA ;
LARSSON, K .
LIFE SCIENCES, 1964, 3 (06) :523-530
[5]  
BARBEAU A, 1969, CAN MED ASSOC J, V101, P791
[6]  
BARBEAU A, 1972, Clinical Research, V20, P948
[7]  
Barbeau A, 1972, Monogr Hum Genet, V6, P114
[8]  
Barbeau A, 1974, Adv Neurol, V5, P347
[9]  
BARBEAU A, 1970, CAN MED ASSOC J, V103, P824
[10]  
BARBEAU A, 1969, LANCET, V2, P1066